About Libera Bio

Libera Bio aims at changing cancer therapy by allowing biologics to cross the cell membrane and reach “undruggable” intracellular targets: the “Holy Grail” in oncology

Top 100 in Life Science
Top 100 in Biopharma
Company Highlights
Year Founded

2018

icon-altEmployees

11

Location (HQ)

ESP

Since Last Funding

1 year 4 months

Monthly Website Visitors

467

icon-altTotal Investment Amt

$1.3M

Last Funding Round

Grant

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Pharmaceutical

Life Science

Biopharma

Biotechnology Research

Oncology